Which agent is known to cause "hand-foot syndrome"?

Which agent is known to cause "hand-foot syndrome"?

• A. Cyclophosphamide
• B. Doxorubicin
• C. Gemcitabine
• D. Paclitaxel

Answer: (B)

The agent known to cause "hand-foot syndrome" is actually not Doxorubicin. Hand-foot syndrome, which is characterized by symptoms such as redness, swelling, pain, and peeling of the skin on the palms of the hands and soles of the feet, is primarily associated with the use of certain chemotherapeutic drugs. Gemcitabine, a nucleoside analogue, is the correct choice linked to this condition. This drug is often utilized to treat various types of cancer, including pancreatic cancer and non-small cell lung cancer. Hand-foot syndrome can occur due to the way Gemcitabine is metabolized and its effects on rapidly dividing cells, particularly in sensitive areas such as the hands and feet. Cyclophosphamide, while it has its own set of side effects, is not typically associated with hand-foot syndrome. Similarly, Paclitaxel may cause peripheral neuropathy and other side effects rather than targeting the hands and feet specifically in the manner observed with Gemcitabine. Doxorubicin, known for its cardiotoxicity, also does not primarily result in hand-foot syndrome. Understanding the specific side effects associated with each chemotherapy agent is crucial for effective patient management and education on what to expect during treatment.

The agent known to cause "hand-foot syndrome" is actually not Doxorubicin. Hand-foot syndrome, which is characterized by symptoms such as redness, swelling, pain, and peeling of the skin on the palms of the hands and soles of the feet, is primarily associated with the use of certain chemotherapeutic drugs.

Gemcitabine, a nucleoside analogue, is the correct choice linked to this condition. This drug is often utilized to treat various types of cancer, including pancreatic cancer and non-small cell lung cancer. Hand-foot syndrome can occur due to the way Gemcitabine is metabolized and its effects on rapidly dividing cells, particularly in sensitive areas such as the hands and feet.

Cyclophosphamide, while it has its own set of side effects, is not typically associated with hand-foot syndrome. Similarly, Paclitaxel may cause peripheral neuropathy and other side effects rather than targeting the hands and feet specifically in the manner observed with Gemcitabine. Doxorubicin, known for its cardiotoxicity, also does not primarily result in hand-foot syndrome.

Understanding the specific side effects associated with each chemotherapy agent is crucial for effective patient management and education on what to expect during treatment.